What is GAVI?
Established in 2000 and headquartered in Geneva, Switzerland, GAVI operates as a unique public-private partnership. The organization functions as a global health alliance, specifically designed to increase equitable access to immunization in lower-income countries. By aggregating demand for vaccines and providing long-term, predictable funding, GAVI has fundamentally transformed the market for pediatric health products. Its market position is defined by its ability to negotiate lower prices for vaccines while simultaneously strengthening health systems to ensure effective delivery. The alliance acts as a critical intermediary between pharmaceutical manufacturers, governments, and international health organizations, effectively mitigating the risks associated with vaccine procurement and distribution in resource-constrained environments.
How much funding has GAVI raised?
GAVI has raised a total of $28M across 2 funding rounds:
Other Financing Round
$25M
Grant
$3M
Other Financing Round (2014): $25M with participation from The Children's Investment Fund Foundation
Grant (2020): $3M led by The UPS Foundation
Key Investors in GAVI
The Children's Investment Fund Foundation
TCI Fund Management is a value-oriented investment firm that focuses on high-quality companies with sustainable competitive advantages, employing a private equity approach to drive long-term outcomes.
The UPS Foundation
The philanthropic arm of UPS, focusing on global logistics expertise and humanitarian aid to support community resilience and health supply chain efficiency.
What's next for GAVI?
Looking ahead, GAVI is poised to enter a new phase of strategic expansion, focusing on the integration of advanced supply chain technologies and the diversification of its vaccine portfolio. The recent capital allocation will likely be directed toward enhancing cold-chain infrastructure and supporting the introduction of new, high-impact vaccines. As the organization moves forward, its focus will remain on achieving sustainable immunization coverage, which is essential for long-term economic stability and public health security in emerging markets. By maintaining its rigorous approach to resource management and strategic partnerships, GAVI is well-positioned to address the evolving demands of global health, ensuring that its mission remains both scalable and impactful in the face of future epidemiological threats.
See full GAVI company page
